PARIS, Mar 9: The Department of Justice (DoJ) is investigating disclosures to the Food & Drug Administration (FDA) about the variable response that certain patients may have to blood-thinner Plavix, Sanofi said. The French drugmaker said in its annual report it became aware of the probe in June 2012 and was cooperating with the DoJ. (agencies)
Trending Now
E-Paper
Follow our WhatsApp channel